Latisse® is Here!

There’s been a growing interest in this product ever since it was introduced. And it’s no wonder. LATISSE® is the first and only FDA-approved prescription treatment for inadequate or not enough eyelashes, growing them longer, fuller and darker.
Discover the LATISSE® difference.
LATISSE® solution is an actual growth treatment. In fact, it’s the only FDA-approved treatment clinically proven to grow lashes. And it’s the only lash growth product of its kind available by prescription. So you’ll need to talk to your doctor to see if it’s right for you.
LATISSE® grows lashes longer, fuller and darker.
LATISSE® solution is a once-a-day treatment you apply topically to the base of your upper eyelashes, as instructed by your doctor. Then, gradually, the results come in. You may start to see more length in as little as 4 weeks and you should achieve full growth in 16 weeks. It’s not an illusion of growth. It’s your own eyelashes — only better.
How LATISSE® works.
LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.
The history behind LATISSE®.
Although LATISSE® is a treatment for inadequate or not enough eyelashes, it was developed through years of research by Allergan, a pharmaceutical leader with expertise in eye care products.
Latisse® FAQ
LATISSE® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker.
Hypotrichosis is another name for having inadequate or not enough eyelashes.
It's a story of how one great product led to another. In 2001, Allergan developed a medicated eye drop used to treat ocular hypertension. Then, a side effect was discovered — patients began growing longer, fuller and darker lashes. This led Allergan to study the active ingredient in this other product, and after a clinical trial, LATISSE® was born, earning its FDA approval in December 2008.
LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase; and second, it increases the number of hairs in this growth phase. The exact way it works is unknown.
The LATISSE® clinical study was conducted at 16 sites across the country and included 278 participants, featuring women and men of various ages (22 to 78), backgrounds and eye colors. Throughout the course of the 16-week treatments, each participant was photographed and evaluated at 4-week intervals (week 0 to week 16) for differences in their overall lash prominence, including elements of length, thickness and fullness. At 16 weeks, the results showed that LATISSE® was effective for 78% of those participating, versus 18% for the vehicle group. Vehicle is the same as LATISSE®, without its active ingredient.
LATISSE® users may start to see longer lashes at 4 weeks, with full growth at 16 weeks. The growth is gradual over time.
LATISSE® solution is a once-a-day treatment you apply yourself each evening to the base of the upper eyelashes. DO NOT APPLY in your eye or to the lower lid, because excess hair growth outside the treatment area may occur.
The clinical studies of LATISSE® were conducted on patients who applied the product to the base of their upper lashes only. DO NOT APPLY in your eye or to the lower lid. There is the potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with the skin surface. It is important to apply LATISSE® only to the skin of the upper eyelid margin at the base of the eyelashes using the accompanying sterile applicators, and to carefully blot any excess LATISSE® from the eyelid margin to avoid its running onto the cheek or other skin areas.
If you miss an application, or a few, don't try to catch up. Just apply the LATISSE® treatment the next evening and stay on schedule.
To achieve the full effect of LATISSE®, you will need to use the product daily for 16 weeks. After that point, you can talk to your doctor about ongoing use.
Contact lens wearers can use LATISSE®. They need to remove their lenses before applying the solution and can reinsert their contacts 15 minutes afterwards.
Yes. In its first year alone, approximately 1.5 million bottles of LATISSE® were prescribed.
The most common side effects after using LATISSE® solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients. LATISSE® solution may cause other less common side effects which typically occur on the skin close to where LATISSE® is applied, or in the eyes. These include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.
If you develop a new ocular condition (e.g., trauma or infection), experience a sudden decrease in visual acuity, have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, you should immediately seek your physician's advice concerning the continued use of LATISSE® solution.
LATISSE® solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. Refer to the illustration below. DO NOT APPLY to the lower eyelid. If you are using other products in the same class for elevated intraocular pressure (IOP), or if you have a history of abnormal IOP, you should only use LATISSE® under the close supervision of your physician.
LATISSE® use may cause darkening of the eyelid skin which may be reversible. LATISSE® use may also cause increased brown pigmentation of the colored part of the eye which is likely to be permanent.
It is possible for hair growth to occur in other areas of your skin that LATISSE® frequently touches. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material to reduce the chance of this from happening. It is also possible for a difference in eyelash length, thickness, fullness, pigmentation (darkness), number of eyelash hairs, and/or direction of eyelash growth to occur between eyes (e.g. results may vary for each eye). These differences, should they occur, will usually go away if you stop using LATISSE®.
LATISSE® solution is an ophthalmic drug product. If any gets into the eye, it is not expected to cause harm. The eye does not need to be rinsed.
Do not use LATISSE® solution if you are allergic to one of its ingredients.
Active ingredient: bimatoprost
Inactive ingredients: benzalkonium chloride; sodium chloride; sodium phosphate, dibasic; citric acid; and purified water. Sodium hydroxide and/or hydrochloric acid may be added to adjust pH. The pH during its shelf life ranges from 6.8 - 7.8.
This is a condition where the pressure inside the eye is higher than normal. LATISSE® may decrease IOP. So talk to your doctor if you are using IOP-lowering medications. Concurrent administration of LATISSE® and certain IOP-lowering medications in ocular hypertensive patients should be closely monitored for changes in intraocular pressure.
Eye redness may occur immediately after use. Consult your doctor if the redness persists or you notice other symptoms as well. If you develop a new eye condition (e.g. trauma or infection), experience a sudden decrease in visual acuity, have eye surgery, or develop any eye reactions, particularly conjunctivitis and eyelid reactions, you should immediately seek your physician's advice concerning the continued use of LATISSE®.
Eye itching may occur immediately after use. Consult your doctor if the itching persists or you notice other symptoms as well. If you develop a new eye condition (e.g. trauma or infection), experience a sudden decrease in visual acuity, have eye surgery, or develop any eye reactions, particularly conjunctivitis and eyelid reactions, you should immediately seek your physician's advice concerning the continued use of LATISSE®.
Increased brown iris pigmentation has occurred when the same formulation of bimatoprost ophthalmic solution was instilled directly into the eye to treat elevated intraocular pressure. Although iris pigmentation was not reported in clinical studies with LATISSE®, patients should be advised about the potential for increased brown iris pigmentation which is likely permanent.
LATISSE® solution is applied topically, along the skin of the upper eyelashes. It is not intended for use in the eyes, but if some solution gets into your eye, you do not need to rinse it.
No. LATISSE® works gradually over the 16-week treatment period. Use of LATISSE® more than once a day will not increase the growth of eyelashes. Please follow the directions, as instructed by your doctor.
LATISSE® received its FDA approval in December 2008, after a team of 16 experienced doctors from all over the country conducted clinical studies. LATISSE® is from Allergan, a specialty pharmaceutical company. Approximately 1.5 million kits of LATISSE® have been sold.
LATISSE® is an ophthalmic solution. If any solution gets into the eye, it is not expected to cause harm. You do not need to rinse your eyes. LATISSE® is not an eye drop. DO NOT APPLY in your eye or to the lower lid.
LATISSE® is the first and only FDA-approved prescription treatment for inadequate or not enough lashes, growing them longer, fuller and darker.
No. LATISSE® does not work in place of mascara. LATISSE® is a solution treatment for inadequate or not enough lashes and requires a prescription from a doctor. However, mascara can be used on your eyelashes in addition to LATISSE®.
If you stop using LATISSE®, your eyelashes are expected to return to their previous appearance over several weeks to months.
LATISSE® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker.
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
If you are using, or have used, prescription products for any eye pressure problems, only use LATISSE® under close doctor care. Although not seen in LATISSE® clinical studies, may cause increased brown pigmentation of the colored part of the eye which is likely permanent. Eyelid skin darkening may occur which may be reversible. Only apply at the base of the upper eyelashes. DO NOT APPLY to the lower eyelid. Hair growth may occur in other skin areas that LATISSE® solution frequently touches. If you develop or experience any eye problems or have eye surgery, consult your doctor immediately about continued use of LATISSE®. The most common side effects after using LATISSE® solution are itchy eyes and/or eye redness. If discontinued, lashes will gradually return to their previous appearance.
Before & After Photos
By law doctors are not allowed to put in pre and post pictures. You may research the various treatments yourself or come in to the clinic to speak to the doctor about them.


on Facebook
on Twitter
our Blog
on Youtube